| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,500 |
378 |
$118K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
661 |
536 |
$98K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,437 |
3,218 |
$94K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,023 |
1,285 |
$91K |
| 80053 |
Comprehensive metabolic panel |
2,390 |
2,095 |
$88K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
384 |
306 |
$84K |
| 36415 |
Collection of venous blood by venipuncture |
5,259 |
3,909 |
$52K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
179 |
148 |
$52K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,428 |
1,188 |
$45K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
210 |
152 |
$29K |
| 80061 |
Lipid panel |
714 |
691 |
$20K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
200 |
165 |
$18K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
904 |
865 |
$17K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
911 |
804 |
$16K |
| 80050 |
General health panel |
85 |
78 |
$15K |
| 84439 |
|
467 |
442 |
$12K |
| 84443 |
Thyroid stimulating hormone (TSH) |
619 |
587 |
$12K |
| 81001 |
|
739 |
639 |
$11K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
215 |
185 |
$11K |
| 83605 |
|
288 |
213 |
$10K |
| J3490 |
Unclassified drugs |
994 |
470 |
$9K |
| 84145 |
|
158 |
112 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
170 |
165 |
$7K |
| 86140 |
|
129 |
107 |
$4K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
309 |
248 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
71 |
62 |
$4K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
62 |
49 |
$3K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
49 |
43 |
$3K |
| 84484 |
|
97 |
74 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
96 |
83 |
$2K |
| 82607 |
|
44 |
43 |
$2K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
15 |
12 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
20 |
19 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
13 |
12 |
$1K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
24 |
24 |
$1K |
| 83880 |
|
16 |
13 |
$1K |
| 83735 |
|
40 |
37 |
$1K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
17 |
15 |
$870.00 |
| 97161 |
|
17 |
14 |
$786.21 |
| 85027 |
|
56 |
53 |
$696.98 |
| 85610 |
|
92 |
63 |
$557.41 |
| 82043 |
|
20 |
17 |
$551.29 |
| 87077 |
|
13 |
12 |
$511.99 |
| 82570 |
|
20 |
17 |
$355.30 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
130 |
25 |
$354.91 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
20 |
13 |
$341.60 |
| 85652 |
|
18 |
15 |
$301.85 |
| 81003 |
|
15 |
14 |
$150.22 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
14 |
14 |
$0.00 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
12 |
12 |
$0.00 |